IRIS

An oral dosage form comprising a pharmaceutical tablet of one or more layers, one of which carries a biologically active substance; the formulation of said tablet includes different percentages of hydrophilic and lipophilic polymeric materials and adjuvant substances. The tablets of the present invention show a release rate which is dependent from the amounts of active substance present in the tablet.

Hydrophilic/lipophilic polymeric matrix dosage formulation

MAGGI, LAURETTA;CONTE, UBALDO;
2007-01-01

Abstract

An oral dosage form comprising a pharmaceutical tablet of one or more layers, one of which carries a biologically active substance; the formulation of said tablet includes different percentages of hydrophilic and lipophilic polymeric materials and adjuvant substances. The tablets of the present invention show a release rate which is dependent from the amounts of active substance present in the tablet.
2007
Chemistry & Analysis covers research on natural and laboratory syntheses, chemical structure, structure-function relationship, isolation and analyses of biologically significant molecules, medicinal and food chemistry. Technical material describing crucial chemical methods in biochemical analysis and research is also placed in this category. Resources covering general biochemistry and natural metabolic pathways are excluded.
US200726336
Maggi Lauretta
ELETTRONICO
Inglese
Internazionale
POLYMER; MATRIX; DOSAGE FORMULATION
6 Brevetti::6.1 Brevetto
none
Maggi, Lauretta; Conte, Ubaldo; Grenier, Pascal; Vergnault, Guy
info:eu-repo/semantics/patent
285
4
6.1 Brevetto
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/202774
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact